NCT04269993View on ClinicalTrials.gov

Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 18, 2022

Primary Completion Date

July 31, 2023

Study Completion Date

July 31, 2023

Conditions
Rheumatoid ArthritisPsoriatic Arthritis
Interventions
DRUG

Cannabis: placebo and medium THC/medium CBD

Vaporized cannabis was administered to participants (placebo and medium THC/medium CBD).

Trial Locations (1)

02903

Brown University School of Public Health, Providence

Sponsors

Lead Sponsor

Brown University
All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Brown University

OTHER

NCT04269993 - Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis | Biotech Hunter | Biotech Hunter